Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Krumbholz M, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl UK, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C; NEMOS (Neuromyelitis Optica Study Group).

Neurol Neuroimmunol Neuroinflamm. 2018 Sep 26;5(6):e504. doi: 10.1212/NXI.0000000000000504. eCollection 2018 Nov.

2.

Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.

Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, Rostásy K, Then Bergh F, Faiss JH, Lieb W, Franke A, Kuhlenbäumer G, Wandinger KP, Leypoldt F; German Network for Research on Autoimmune Encephalitis (GENERATE).

Ann Neurol. 2018 Apr;83(4):863-869. doi: 10.1002/ana.25216.

PMID:
29572931
3.

Information processing deficits as a driving force for memory impairment in MS: A cross--sectional study of memory functions and MRI in early and late stage MS.

Köhler W, Fischer M, Bublak P, Faiss JH, Hoffmann F, Kunkel A, Sailer M, Schwab M, Stadler E, Zettl UK, Penner IK; HIPPOCOMS Study Group.

Mult Scler Relat Disord. 2017 Nov;18:119-127. doi: 10.1016/j.msard.2017.09.026. Epub 2017 Sep 25.

PMID:
29141793
4.

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.

Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Young KL, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl U, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Kleiter I; NEMOS (Neuromyelitis Optica Study Group).

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):639-647. doi: 10.1136/jnnp-2017-315603. Epub 2017 Jun 1.

5.

Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod.

Sinnecker T, Othman J, Kühl M, Metz I, Niendorf T, Kunkel A, Paul F, Wuerfel J, Faiss J.

Case Rep Neurol Med. 2016;2016:5876798. Epub 2016 Nov 22.

6.

Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.

Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Weissert R, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Rückriem L, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Hellwig K; NEMOS (Neuromyelitis Optica Study Group).

Mult Scler. 2017 Jul;23(8):1092-1103. doi: 10.1177/1352458516671203. Epub 2016 Oct 6.

PMID:
27758954
7.

Escalation Therapy of Steroid Refractory Multiple Sclerosis Relapse with Tryptophan Immunoadsorption - Observational Multicenter Study with 147 Patients.

Schimrigk S, Faiss J, Köhler W, Günther A, Harms L, Kraft A, Ehrlich S, Eberl A, Fassbender C, Klingel R, Galle J, Riedlinger A, Hoffmann F.

Eur Neurol. 2016;75(5-6):300-6. doi: 10.1159/000447059. Epub 2016 Jun 16.

PMID:
27304890
8.

7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study.

Sinnecker T, Othman J, Kühl M, Mekle R, Selbig I, Niendorf T, Kunkel A, Wienecke P, Kern P, Paul F, Faiss J, Wuerfel J.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 29;2(6):e171. doi: 10.1212/NXI.0000000000000171. eCollection 2015 Dec.

9.

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Stellmann JP, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker R, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Winkelmann A, Marouf W, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C; Neuromyelitis Optica Study Group.

Ann Neurol. 2016 Feb;79(2):206-16. doi: 10.1002/ana.24554. Epub 2015 Nov 26.

PMID:
26537743
10.

Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis.

Kunkel A, Fischer M, Faiss J, Dähne D, Köhler W, Faiss JH.

Front Neurol. 2015 May 11;6:97. doi: 10.3389/fneur.2015.00097. eCollection 2015.

11.

How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?

Fischer M, Kunkel A, Bublak P, Faiss JH, Hoffmann F, Sailer M, Schwab M, Zettl UK, Köhler W.

J Neurol Sci. 2014 Aug 15;343(1-2):91-9. doi: 10.1016/j.jns.2014.05.042. Epub 2014 May 27. Review.

PMID:
24950898
12.

Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study.

Faiss JH, Dähne D, Baum K, Deppe R, Hoffmann F, Köhler W, Kunkel A, Lux A, Matzke M, Penner IK, Sailer M, Zettl UK.

BMJ Open. 2014 Apr 10;4(4):e004409. doi: 10.1136/bmjopen-2013-004409.

13.

[Interdisciplinary neurovascular network: a new structure for treatment of stroke and other cerebrovascular diseases in Germany].

Busse O, Röther J, Faiss J, Hamann GF, Hupp T, Jansen O, Meixensberger J, Neumann-Haefelin T, Schackert G, Ringelstein EB.

Nervenarzt. 2013 Oct;84(10):1228-32. doi: 10.1007/s00115-013-3848-y. German. No abstract available.

PMID:
24048549
14.

[Regional and national stroke units in Germany: amended certification criteria].

Nabavi DG, Ringelstein EB, Faiss J, Kessler C, Röther J, Busse O.

Nervenarzt. 2012 Aug;83(8):1039-52. doi: 10.1007/s00115-012-3594-6. German.

PMID:
22801666
15.

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Bergh FT, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Münch C, Winkelmann A, Zettl U UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F.

J Neuroinflammation. 2012 Jan 19;9:14. doi: 10.1186/1742-2094-9-14.

16.

Early development of spasticity following stroke: a prospective, observational trial.

Wissel J, Schelosky LD, Scott J, Christe W, Faiss JH, Mueller J.

J Neurol. 2010 Jul;257(7):1067-72. doi: 10.1007/s00415-010-5463-1. Epub 2010 Feb 6.

17.

[New developments in German stroke units].

Faiss JH, Busse O, Ringelstein EB.

Nervenarzt. 2008 Apr;79(4):480-2. doi: 10.1007/s00115-007-2401-2. German. No abstract available.

PMID:
18210047
18.

Cognitive dysfunction in different stages in multiple sclerosis--presentation of 3 cases.

Faiss JH.

J Neurol. 2007 May;254 Suppl 2:II77-9. Erratum in: J Neurol. 2008 Feb;255(2):309-10.

PMID:
17503135
19.

Cognition in the early stage of multiple sclerosis.

Schulz D, Kopp B, Kunkel A, Faiss JH.

J Neurol. 2006 Aug;253(8):1002-10. Epub 2006 Apr 11.

PMID:
16609812
20.

Localization of a cerebellar timing process using PET.

Jueptner M, Rijntjes M, Weiller C, Faiss JH, Timmann D, Mueller SP, Diener HC.

Neurology. 1995 Aug;45(8):1540-5.

PMID:
7644055
21.

Liposarcoma with unusual neurological manifestations.

Timmann D, Faustmann PM, Faiss JH, Schmidt U, Kryne-Kubat B.

Clin Neuropathol. 1995 Jan-Feb;14(1):37-41.

PMID:
7729079
22.

Superficial siderosis of the central nervous system.

Heye N, Kastrup O, Terstegge K, Faiss JH, Iglesias JR.

Arch Gerontol Geriatr. 1994 May-Jun;18(3):181-90.

PMID:
15374298
23.

Oculomotor abnormalities and MRI findings in idiopathic cerebellar ataxia.

Fetter M, Klockgether T, Schulz JB, Faiss J, Koenig E, Dichgans J.

J Neurol. 1994 Feb;241(4):234-41.

PMID:
8195823
24.

[Cerebral angiitis or central side effects after lumbar myelography (with intracerebral vascular spasm)].

May A, Faiss J, Keidel M, Schwarz M, Weiller C.

Nervenarzt. 1994 Feb;65(2):125-7. German.

PMID:
8164765
25.

[Recurrent lung embolisms in aneurysm of the popliteal vein].

Lang E, Bouwman O, Faiss J.

Chirurg. 1993 Jun;64(6):503-4. German.

PMID:
8359064
26.

[Aneurysm of the gastroduodenal artery with aplasia of the celiac trunk].

Vogler C, Faiss J, Krause FJ, Schwamborn G.

Chirurg. 1991 Jun;62(6):503-4. German. No abstract available.

PMID:
1914650
27.

Selective impairment of smooth-pursuit eye movements due to an ischemic lesion of the basal pons.

Thier P, Bachor A, Faiss J, Dichgans J, Koenig E.

Ann Neurol. 1991 Apr;29(4):443-8.

PMID:
1929215
28.

Multiple supratentorial hemangioblastomas following primary infratentorial manifestation.

Faiss J, Wild G, Schroth G, Heiss E, Melms A.

Clin Neuropathol. 1991 Jan-Feb;10(1):21-5.

PMID:
2015722
29.

The development of infratentorial atrophy in patients with idiopathic cerebellar ataxia of late onset: a CT study.

Klockgether T, Faiss J, Poremba M, Dichgans J.

J Neurol. 1990 Nov;237(7):420-3.

PMID:
2273411
30.

Central spinal cord lesions in stenosis of the cervical canal.

Faiss JH, Schroth G, Grodd W, Koenig E, Will B, Thron A.

Neuroradiology. 1990;32(2):117-23.

PMID:
2398937

Supplemental Content

Support Center